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Abstract The purpose of this study was to analyze the
impact of monopolar radiofrequency energy treatment on
subchondral bone viability. The femoral grooves of six
chinchilla bastard rabbits were exposed bilaterally to
monopolarradiofrequencyenergyfor2,4and8 s,creatinga
total of 36 defects. An intravital ﬂuorescence bone-labeling
technique characterized the process of subchondral bone
mineralization within the 3 months following exposure to
radiofrequency energy and was analyzed by wideﬁeld epi-
ﬂuorescence optical sectioning microscopy using an Apo-
Tome. After 2 s of radiofrequency energy exposure, regular
ﬂuorescencestainingofthesubchondralbonewasevidentin
all samples when compared to untreated areas. The depth of
osteonecrosis after 4 and 8 s of radiofrequency energy
treatment averaged 126 and 942 lm at 22 days (P\.05;
P\.01). The 4 s treatment group showed no osteonecrosis
after 44 days whereas the depth of osteonecrosis extended
from 519 lm at 44 days (P\.01), to 281 lm at 66 days
(P\.01) and to 133 lm at 88 days (P\.05) after 8 s of
radiofrequency energy application. Though radiofrequency
energy may induce transient osteonecrosis in the superﬁcial
zone of the subchondral bone, the results of this study sug-
gest that post-arthroscopic osteonecrosis appears to be of
only modest risk given the current clinical application in
humans.
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Introduction
In recent years, radiofrequency energy (RFE) devices have
been widely used for arthroscopic thermal chondroplasty;
however, their beneﬁt has become more and more contro-
versial. Thetreatmentaims tocontourandsmoothﬁbrillated
cartilage surface, decrease inﬂammatory response and pre-
vent further collagen and proteoglycan loss through the
preservation of chondrocyte viability [1, 2]. Several inves-
tigations have revealed increasing evidence that RFE treat-
ment may result in signiﬁcant chondrocyte cell death,
including partial involvement of the subchondral bone layer
[3–11]. As a result, an association between RFE treatment
and osteonecrosis has been hypothesized; however, the
actual effect of RFE on subchondral bone viability remains
to be elucidated [4, 5, 12, 13].
The dynamic process of bone formation, remodeling and
regeneration in vivo can be examined by polychrome
labeling using calcium-binding ﬂuorochromes [14, 15].
Fluorochromes are only deposited at sites of active min-
eralization, thus they provide information regarding the
temporal progression of bone remodeling processes and the
direction of bone formation. To prove the hypothesis that
monopolar RFE treatment might result in depletion of
subchondral bone viability, an intravital ﬂuorescence bone-
labeling technique was used to investigate changes in bone
mineralization within 3 months after RFE exposure in a
rabbit in vivo model.
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All animal experiments were performed with the approval
of our institutional review board and the local government
animal rights protection authorities. A total of twelve knees
in six adult female rabbits (Chinchilla Bastard, body weight
[3 kg) were used for this study. Animals were anesthe-
tized with ketamine (0.8 mg/kg body weight) and xylazine
(5 mg/kg body weight) intramuscularly. A medial parapa-
tellar incision was made followed by lateral dislocation of
the patella, which exposed the femoral groove. Using the
Arthrex AR9600
 Orthopaedic Procedure Electrosurgical
System and the Arthrex AR-9603-60 ablation probe
(Bovie Medical Corporation St. Petersburg, Florida, USA),
monopolar RFE was applied through continuous, stationary
delivery for 2, 4 and 8 s on three different points of each
femoral groove creating a total of 36 defects. The probe tip
of the electrode was held stationary in freehand light-
contact mode to simulate operating room conditions. One
surgeon (P. B.) performed all operations. The power setting
was used as recommended by the manufacturer (Preset 7,
40 Watt) and continuous, room temperate lavage solution
(Ringer’s lactate) was applied manually through a syringe
during RFE application.
After RFE application layer-to-layer suturing of the
medial retinaculum, and skin was performed using
4.0 Vicryl (Ethicon
, a Johnson & Johnson Company,
Langhorne, Pennsylvania, USA). Postoperatively, animals
received an analgesic treatment with Carprofen (5 mg/kg
body weight) subcutaneously for 3 days. Within the fol-
lowing three-month period, all animals were housed in
deep litter and showed species-appropriate behavior. None
of the animals developed patellar luxation.
Intravital ﬂuorescence bone labeling
After the operative procedure, all animals received a
ﬂuorescence agent (Merck, Darmstadt, Germany) every
22 days to label bone formation. Fluorescence agents are
only deposited into vital bone at sites of active minerali-
zation [14, 15]. Injections were administered subcutane-
ously according to the following schedule: Day 22—
xylenol-orange (90 mg/kg body weight), Day 44—calcein
green (10 mg/kg body weight), Day 66—alizarin-com-
plexone red (30 mg/kg body weight), Day 88—tetracycline
(25 mg/kg body weight). A three-month period was con-
sidered sufﬁcient to investigate not only signs of osteone-
crosis but also bone remodeling and regeneration in this
animal model, using four different ﬂuorochromes [16].
After 3 months, animals were euthanized, and the distal
femora were harvested. Soft tissue and musculature were
removed, and the femora were defatted in an alcohol series
and embedded in methylmethacrylate. After solidiﬁcation,
150 (±10) lm-thick sections were cut perpendicular to the
longitudinal axis of the femur with a Leica SP 1600
innerhole saw-microtome (Leica, Bensheim, Germany).
The saw blade had a thickness of 300 lm. The thickness
of each slide was conﬁrmed with a measuring device
speciﬁcally for evaluating histological sections (Leica,
Bensheim, Germany).
High-resolution microradiography
Microradiographs were performed on samples from the
central section of each defect with KODAK Professional
Industrex SR45 ﬁlm (100NIF) and the Faxitron Microfocus
Cabinet radiograph system (Hewlett-Packard, 50 lm x-ray
beam output; Model 43855A; Buffalo Grove, Illinois,
USA). The bone sections were exposed to 40 kV for 6 min.
The ﬁlm was analyzed by light microscopy and a digital
image processing system (Quantimet system, Leica DM-
RXE, Bensheim, Germany).
Microscopy
After the microradiographic procedure, sections were
mounted on slides for microscopic analysis. Samples were
analyzed and viewed on a Leica DM-IRBE microscope and
on a Leica MZ-5 stereomacroscope (Leica Microsystems,
Bensheim, Germany) for standard ﬂuorescence microscopy.
The optically sectioned ﬂuorescence images were generated
on an AxioObserver Z.1 microscope equipped with an
ApoTomeslider(CarlZeiss,Inc,Germany).Settingswereas
follows: luminous source—EXFO X-Cite Series 120; ﬁlter
sets—49, 38 HE and 43; objective—EC Plan-NEOFLUAR
10x/0.3; scale—0.65 lm/pixel; grid—VL; camera—Axio-
Cam MRm 1388 9 1040 pixel; software—AxioVi-
sion 4.6.3.0 (Carl Zeiss, Inc, Germany). The ApoTome
principle uses a grid of stripes that is inserted into the
microscope’s ﬁeld stop plane and thus projected onto the
object. As the high spatial frequency of the grid rapidly
attenuates with defocus, its modulation serves as a ‘‘focus
label’’. The grid is shifted laterally in three deﬁned steps
relative to the sample. A camera takes a picture in each grid
position. The three raw images are combined into a resultant
optically sectioned image by on-line computation.
The depth of osteonecrosis was determined in the ﬂuo-
rescence preparations with a modiﬁed method according to
Caffey et al. [3] (Fig. 1). Images were digitally acquired
and analyzed with the help of the Leica QwinV3 System
(Leica Microsystems, Bensheim, Germany). To measure
the time dependence of osteonecrosis depth, a tangential
line was drawn along the tidemark of the zone of calciﬁed
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123cartilage. From this line, a second line was drawn at an
angle of 90; the line extended to the depth of either
xylenol, calcein, alizarin or tetracyclin ﬂuorescence stain-
ing representing subchondral bone mineralization on day
22, 44, 66 and 88, respectively. For each ﬂuorochrome, six
measurements were performed in the central aspect of each
defect. Measurements were also performed in sham-oper-
ated areas of the femoral groove that were localized
between RFE application points to provide a baseline of
physiological bone mineralization beneath the tidemark in
this animal model within a three-month period. The depth
of osteonecrosis was deﬁned as the difference between
depths of ﬂuorescence staining of the treatment groups
and the sham group measured separately for each
ﬂuorochrome.
Statistical analysis
Statistical analyses were performed with GraphPad Prism

(Prism 4 Statistics Guide -Statistical analyses for laboratory
and clinical researchers, GraphPad Software, Inc., San
Diego, California, USA, 2003). Mean values and standard
deviationsarepresented.Theone-wayANOVAfollowedby
Dunnett’s Multiple Comparison post-test was used to com-
pare the treatment groups with the sham group. A P value
less than .05 was considered statistically signiﬁcant.
Results
A total of 36 defects were evaluated. Twelve defects rep-
resented each exposure time (2, 4 or 8 s of monopolar
RFE). Fluorescence microscopy conﬁrmed standard
administration of all ﬂuorescence agents for every animal
with the typical time-dependent ﬂuorochrome deposition
(Fig. 2).
Table 1 and Fig. 3 summarize the time course of sub-
chondral bone mineralization of sham-operated and RFE-
treated areas during the three-month period. In untreated
areas, mean depth of subchondral bone mineralization
beneath the tidemark was 145 ± 117 lm at 22 days,
143 ± 73 lm at 44 days, 134 ± 63 lm at 66 days and
110 ± 59 lm at 88 days.
After 2 s of RFE exposure, regular ﬂuorescence staining
of the subchondral bone was evident in all samples when
compared to untreated areas (Fig. 4a, b). Mean depth of
subchondral bone mineralization beneath the tidemark
was 130 ± 58 lm at 22 days, 124 ± 63 lm at 44 days,
136 ± 75 lm at 66 days and 93 ± 75 lm at 88 days
Tetracyclin, Day 88
Alizarin, Day 66
Calcein, Day 44
Xylenol, Day 22
HC
TM
Bone
Fig. 1 Femoral groove cross-section to measure radiofrequency
energy-induced thermal injury in a modiﬁed protocol according to
Caffee et al. Arrowheads indicate time-dependent depth of thermal
injury indicated by the demarcated half-circle of stained and
unstained bone measured separately for xylenol, calcein, alizarin
and tetrazyclin (HC Hyaline cartilage, TM Tidemark)
Fig. 2 Deposition of ﬂuorescence agents: Day 22—xylenol orange,
Day 44—calcein green, Day 66—alizarin-komplexon red, Day 88—
tetracycline yellow
Table 1 Summary of the time course of subchondral bone mineral-
ization of sham-operated and RFE-treated areas during the three-
month period
Sham 2 s 4 s 8 s
Xylenol (day
22)
145 ± 117 130 ± 58 271 ± 174* 1087 ± 201*
Calcein (day 44) 143 ± 73 124 ± 63 162 ± 123 662 ± 207*
Alzarin (day 66) 134 ± 63 136 ± 75 150 ± 84 415 ± 142*
Tetrazyclin (day
88)
110 ± 59 93 ± 75 117 ± 65 243 ± 90*
Xylenol, calcein, alizarin and tetracyclin ﬂuorescence staining rep-
resents subchondral bone mineralization beneath the tidemark on day
22, 44, 66 and 88 after RFE exposure. Values presented in lm
* P\.05 (one-way ANOVA followed by Dunnett’s Multiple Com-
parison post-Test)
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123showing no signiﬁcant difference in comparison with
untreated areas (P[.05).
After 4 s of exposure, a signiﬁcant recess of ﬂuores-
cence labeling in the superﬁcial zone of the subchondral
bone layer was evident, extending to a mean maximum
depth of 271 ± 174 lm at 22 days (P\.01) (Fig. 4c).
Depth of ﬂuorescence labeling decreased to 162 ± 123 lm
at 44 days (P[.05) to 150 ± 84 lm at 66 days (P[.05)
and to 117 ± 65 lm at 88 days (P[.05).
After 8 s of RFE application ﬂuorescence labeling of
vital bone extended to a mean maximum depth of
1087 ± 201 lm at 22 days (P\.01), decreased to a mean
depth of 662 ± 207 lm at 44 days (P\.01) to
415 ± 142 lm at 66 days (P\.01) and to 243 ± 90 lm
at 88 days (P\.01).
Our data show an average effective depth of osteone-
crosis after 4 and 8 s of RFE treatment of 126 and 942 lm
at 22 days. The 4 s treatment group showed no osteone-
crosis after 44 days whereas the depth of osteonecrosis
decreased to 519 lm at 44 days, to 281 lm at 66 days and
to 133 lm at 88 days after 8 s of RFE application.
No structural differences in subchondral bone mor-
phology were observed between treated and untreated
samples when analyzed by microradiography, i.e., areas
of osteonecrosis were not detectable with this method
(Figs. 5a–d, 6).
Discussion
The most important ﬁnding of the present study was that
depletion of subchondral bone viability might occur as a
result of exposure to monopolar RFE. Several recent
0
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m
Fig. 3 Time course and depths of ﬂuorescence labeling of vital
subchondral bone beneath the tidemark over a three-month period in
sham-operated and in RFE-treated areas after 2, 4 and 8 s of RFE
application
Fig. 4 a–d Each ﬁgure represents a cross-section through the femoral
groove analyzed by ﬂuorescence microscopy. a Shows an untreated
area with regular deposition of the ﬂuorescence agents and the weakly
labeled intact articular cartilage. b Shows the central section of an
area after 2 s of RFE exposure. The RFE probe created a half-
thickness cartilage crater while subchondral bone mineralization
remains regular. c Shows the central section of an area after 4 s of
RFE exposure. A full-thickness cartilage defect is weakly labeled. In
addition, a small recess of active bone mineralization is clear.
d Shows an area after 8 s of RFE exposure. This sample yielded a
well-demarcated half-circle border between the clearly stained vital
and the unstained dead subchondral bone
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123studies have investigated the effect of RFE devices on
articular cartilage [1–6, 8–11, 17, 18]. Though thermal
chondroplasty results in a smooth, contoured ﬁbrillated
cartilage surface and restored mechanical properties, det-
rimental consequences on chondrocyte viability have been
reported with extended cartilage loss [6, 18]. Different
experimental settings yield contradictory results with
regard to the extent of chondrocyte cell death and damage
to the underlying matrix. Visual examination by the sur-
geon is not sufﬁcient to measure cellular damage. The
clinical use of RFE is becoming more worrisome and many
authors recommend a cautious approach toward the clinical
use of RFE devices [5, 17].
Objective measurements of cell viability support the
conclusion that RFE has the capability to cause signiﬁcant
chondrocyte cell death potentially extending to the level of
the subchondral bone layer [3–5]. However, the actual
effect of RFE on bone has not been investigated in detail,
and avascular necrosis remains a major concern when
thermally treating cartilage [3, 13]. Therefore, this study
was designed to determine the effect of RFE on subchon-
dral bone viability using an intravital ﬂuorescence bone-
labeling technique. Our goal was not to determine the
optimal conditions for performing thermal chondroplasty.
Secondary osteonecrosis of the knee has been previously
described in case reports and small case series, both lack-
ing comprehensive information on the pathophysiology.
After conventional arthroscopy with partial meniscal
resection an increased load transmitted to the already
injured cartilage has been hypothesized to result in sub-
chondral microfractures or changes in the subchondral
blood supply, typically leading to avascular necrosis in the
elderly [19, 20]. Although laser-assisted surgery-induced
Fig. 5 a–d Each ﬁgure shows a cross–section through the femoral groove analyzed by microradiography. No difference in bone morphology
was observed after 2 s (b), 4 s (c) and 8 s (d) of RFE exposure in comparison with sham-operated bone (a)
Fig. 6 ApoTome-generated ﬂuorescence picture at the verge of an
area after 8 s of RFE exposure. Double-headed arrow shows the
treatment area with a full-thickness cartilage defect. Note the zone of
osteonecrosis with the time-dependent remineralization. (Arrowhead
Day 22; open arrow Day 44; large solid arrow Day 66; small solid
arrow Day 88 (weakly pictured); blue autoﬂuorescence)
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123osteonecrosis as a result of thermal or photoacoustic tissue
damage to the underlying matrix has been described, few
reports have considered that a similar effect could result
from the use of RFE devices [12, 13, 21, 22]. Most
recently, Bonutti and colleagues presented a series of
nineteen patients treated with knee arthroplasty for osteo-
necrosis. In this study, ten patients had undergone previous
arthroscopy with associated RFE treatment. However, in
their review of eleven reports, post arthroscopic osteone-
crosis of the knee occurred most often after laser-assisted
surgery or after an arthroscopic meniscectomy utilizing a
standard basket punch. In only one report was osteone-
crosis associated with the use of an RFE device. Therefore,
the extent to which osteonecrotic lesions are due to applied
energy from RFE devices, or to the often simultaneously
performed meniscectomy is still under debate [13, 19, 20].
Heating of the cartilage surface with heat shock-induced
chondrocyte cell death has been described in several
reports after RFE treatment [6, 9–11]. The temperature at
the surface and below the surface of the articular cartilage
adjacent to the RFE probe reached 66–74C upon stimu-
lation with a monopolar device [23, 24]. Such temperatures
induce heat shock necrosis in osteoblasts [25]. Using the
experimental settings of our study, we demonstrated that
RFE has the potential to induce thermal injury to the
superﬁcial subchondral bone layer with increasing treat-
ment time. Thus, this study supports the aforementioned
hypothesis that monopolar RFE treatment might result in
depletion of subchondral bone viability. Osteonecrosis
averaged a maximum depth of 126 lm after 4 s and
942 lm after 8 s of exposure. Though recent clinical
studies found no incidents of avascular necrosis 6 or
12 months after RFE treatment and, when compared to
mechanical shaving, thermal chondroplasty resulted in
greater smoothing of chondromalacic cartilage with
decreasedtotaltissueeffects,itremainstobeprovenwhether
focal osteonecrotic lesions occur more frequently under
clinical conditions than previously expected, becoming
symptomatic in only in a small number of patients due to a
stepwise regeneration [7, 26, 27].
The time course of bone regeneration in our study was
markedly slowed in comparison with previous studies,
supporting recent ﬁndings that heat-injured bone maintains
only an inferior capacity to regenerate [16, 28]. Recent
studies have shown that revascularization begins one to
2 weeks after radiofrequency thermal balloon angioplasty,
but is not complete until 4 weeks following treatment [29].
Thus, the delayed progress of bone regeneration in our
study may result from thermal injury not only to bone but
also to vascular structures, depriving subchondral tissue of
the blood supply required for rapid growth.
The intravital ﬂuorescence bone-labeling technique
allows investigation of the dynamic process of bone
remodeling, representing the major advantage of this study.
Nevertheless, several limitations deserve mention. First,
during clinical use, RFE may be applied to cartilage in a
‘‘paint brush’’ manner—devices are not typically held
stationary. Thus, according to Caffee et al. [3], we chose
short treatment times to limit this effect. Second, our ani-
mal model did not support an arthroscopic procedure. The
open surgery technique used in this study included the risk
that the ﬂowing irrigation ﬂuid did not continuously sur-
round the probe tip of the RFE device as is assured under
arthroscopic settings. Thus, the temperature at the probe tip
and the underlying tissue may have exceeded temperatures
obtained under clinical conditions. In addition, we used
room temperate lavage solution during RFE application
though it has been shown that thermal chondroplasty with
37C lavage solution resulted in less depth of chondrocyte
death than with 22C solution temperature [9]. However,
room temperate lavage solution reﬂects more standard
clinical settings. Third, cartilage thickness in our animal
model was about one-fourth that of human cartilage; as
cartilage tends to act as an insulator more energy may have
been delivered to the subchondral bone than would occur in
most circumstances under clinical applications in humans.
However, Caffee and colleagues demonstrated that four out
of ﬁve devices penetrated the full thickness of the cartilage
to the bone with a treatment time of 3 s when applied to
grade III cartilage defects in humans [3]. In addition,
temperature requirements to achieve morphological change
in articular cartilage are lower in already arthritic cartilage
when compared to nonartritic cartilage [30]. These factors
might inﬂuence the true effect of monopolar RFE when
applied to arthritic articular cartilage and subsequently to
subchondral bone under clinical settings. Fourth, we did
not perform a power analysis. However, six measurements
were performed in the central aspect of each defect.
Twelve defects represented a 2, 4 or 8 s treatment time,
respectively, resulting in 72 single measurements of each
RFE exposure time. We do believe that this approach
provided reliable data with respect to statistically signiﬁ-
cant differences. Finally, this study investigated the effect
of only one RFE device. Different devices may exert
varying effects on subchondral bone, depending on the
energy setting, the probe tip design and the use of mono-
polar or bipolar energy in a non-contact or light-contact
mode. However, the use of additional RFE devices was
beyond the scope of this study.
Several recent studies have investigated the effect of
RFE devices on articular cartilage and found detrimental
consequences on chondrocyte viability with extended car-
tilage loss. In addition, data from our study indicate that the
impact of monopolar RFE might result in depletion of
subchondral bone viability with increasing treatment time.
This ﬁnding is of clinical relevance as the ﬁeld of RFE
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123application is not limited to thermal chondroplasty. For
example, RFE devices are used for notch preparation in
anterior cruciate ligament reconstruction where RFE
operates directly on bony tissue.
Conclusions
To the best of our knowledge, this is the ﬁrst in vivo study
to investigate possible RFE side effects on subchondral
bone viability. With the described limitations and factors,
which could not be added in the study design, the results of
our study support the conclusion that increasing RFE
treatment time may induce a focal, potentially transient
osteonecrosis in the superﬁcial zone of the subchondral
bone. Under these conditions, the critical application time
of monopolar RFE with regard to osteonecrosis was about
4 s of stationary delivery. Given the results of our study,
with only a limited extent of osteonecrosis as a result of a
relatively long stationary delivery of RFE, we would
conclude that the complication of postarthroscopic osteo-
necrosis appears to be only a modest risk with the current
clinical application mode (paint-brush pattern, short treat-
ment time) in humans.
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